Artisan Partners Limited Partnership Amarin Corp Plcuk Transaction History

Artisan Partners Limited Partnership

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$4.04 - $5.31 $21 Million - $27.6 Million	-5,192,890 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.64 - $7.76 $40.6 Million - $86.6 Million	-11,158,723 Reduced 68.24%	5,192,890 $21.9 Million
Q2 2020 Aug 12, 2020	SELL	$4.78 - $8.26 $764,503 - $1.32 Million	-159,938 Reduced 0.97%	16,351,613 $113 Million
Q1 2020 May 12, 2020	BUY	$4.0 - $21.53 $1.82 Million - $9.82 Million	456,130 Added 2.84%	16,511,551 $66 Million
Q4 2019 Feb 12, 2020	BUY	$13.94 - $24.12 $40.6 Million - $70.2 Million	2,911,233 Added 22.15%	16,055,421 $344 Million
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $180 Million - $301 Million	12,982,428 Added 8025.73%	13,144,188 $199 Million
Q2 2019 Aug 09, 2019	BUY	$16.27 - $20.51 $1.04 Million - $1.31 Million	63,860 Added 65.23%	161,760 $3.14 Million
Q1 2019 May 10, 2019	BUY	$12.61 - $22.33 $325,262 - $575,980	25,794 Added 35.77%	97,900 $2.03 Million
Q4 2018 Feb 12, 2019	BUY	$12.41 - $22.98 $894,835 - $1.66 Million	72,106 New	72,106 $981,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.